{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:55:43Z","timestamp":1794639343201,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ80005"],"award-info":[{"award-number":["2022JJ80005"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Disabled Rehabilitation Association Foundation of Hunan Province","award":["2023XK0224"],"award-info":[{"award-number":["2023XK0224"]}]},{"DOI":"10.13039\/501100019054","name":"Changsha Science and Technology Project","doi-asserted-by":"publisher","award":["kh2401012"],"award-info":[{"award-number":["kh2401012"]}],"id":[{"id":"10.13039\/501100019054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05694-6","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T22:12:55Z","timestamp":1746828775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC"],"prefix":"10.1186","volume":"25","author":[{"given":"Aoxiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"5694_CR1","doi-asserted-by":"publisher","unstructured":"Zhang J et al. Germline mutations in predisposition genes in pediatric cancer, (in eng). N Engl J Med, 373, 24, pp. 2336\u201346, Dec 10 2015, https:\/\/doi.org\/10.1056\/NEJMoa1508054","DOI":"10.1056\/NEJMoa1508054"},{"key":"5694_CR2","doi-asserted-by":"publisher","unstructured":"Dimaras H, et al. Retinoblastoma, (in eng). Nat Rev Dis Primers. Aug 27 2015;1:15021. https:\/\/doi.org\/10.1038\/nrdp.2015.21.","DOI":"10.1038\/nrdp.2015.21"},{"key":"5694_CR3","doi-asserted-by":"publisher","first-page":"963780","DOI":"10.3389\/fonc.2022.963780","volume":"12","author":"CC Cruz-G\u00e1lvez","year":"2022","unstructured":"Cruz-G\u00e1lvez CC, Ordaz-Favila JC, Villar-Calvo VM, Cancino-Marentes ME, Bosch-Canto V. Retinoblastoma: review and new insights (in eng). Front Oncol. 2022;12:963780. https:\/\/doi.org\/10.3389\/fonc.2022.963780.","journal-title":"Front Oncol"},{"key":"5694_CR4","doi-asserted-by":"publisher","unstructured":"Yao Y, Gu X, Xu X, Ge S, Jia R. Oct 28, Novel insights into RB1 mutation, (in eng), Cancer Lett, 547, p. 215870, 2022, https:\/\/doi.org\/10.1016\/j.canlet.2022.215870","DOI":"10.1016\/j.canlet.2022.215870"},{"key":"5694_CR5","doi-asserted-by":"publisher","unstructured":"M\u00fchlenberg T et al. KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1\/2 Inhibition as Salvage Strategy, (in eng), Mol Cancer Ther, vol. 18, no. 11, pp. 1985\u20131996, Nov 2019. https:\/\/doi.org\/10.1158\/1535-7163.Mct-18-1224","DOI":"10.1158\/1535-7163.Mct-18-1224"},{"key":"5694_CR6","doi-asserted-by":"publisher","unstructured":"Uusitalo E, et al. Incidence and mortality of neurofibromatosis: A total population study in Finland. J Invest Dermatology. 2015\/3\/1;135(3):904\u20136. https:\/\/doi.org\/10.1038\/jid.2014.465.","DOI":"10.1038\/jid.2014.465"},{"key":"5694_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/eb.S255184","volume":"12","author":"M Nebbioso","year":"2020","unstructured":"Nebbioso M, et al. Neurofibromatosis type 1: ocular electrophysiological and perimetric anomalies (in eng). Eye Brain. 2020;12:119\u201327. https:\/\/doi.org\/10.2147\/eb.S255184.","journal-title":"Eye Brain"},{"key":"5694_CR8","doi-asserted-by":"publisher","unstructured":"Romero-Titos A, \u00c1lvarez-S\u00e1nchez P, Fern\u00e1ndez FMH, Castro-G\u00f3mez M, Blasco BB. Retinal astrocytic Hamartoma: A rare ocular presentation in neurofibromatosis type 2 (in eng). J Fr Ophtalmol. Nov 2023;46(9):e317\u201320. https:\/\/doi.org\/10.1016\/j.jfo.2023.03.013.","DOI":"10.1016\/j.jfo.2023.03.013"},{"key":"5694_CR9","doi-asserted-by":"publisher","unstructured":"Hilton DA, Hanemann CO. Schwannomas and their pathogenesis, (in eng), brain pathol. Pp 205\u2013 20 Apr. 2014;24(3). https:\/\/doi.org\/10.1111\/bpa.12125.","DOI":"10.1111\/bpa.12125"},{"key":"5694_CR10","doi-asserted-by":"publisher","unstructured":"Daniels AB et al. Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance, (in eng), Cancer, vol. 129, no. 19, pp. 2927\u20132940, Oct 1., 2023, https:\/\/doi.org\/10.1002\/cncr.34896","DOI":"10.1002\/cncr.34896"},{"key":"5694_CR11","doi-asserted-by":"publisher","unstructured":"Mazumder S, Higgins PJ, Samarakoon R. Downstream Targets of VHL\/HIF-\u03b1 Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance, (in eng), Cancers (Basel), vol. 15, no. 4, Feb 19 2023, https:\/\/doi.org\/10.3390\/cancers15041316","DOI":"10.3390\/cancers15041316"},{"key":"5694_CR12","doi-asserted-by":"publisher","unstructured":"Karimi S, Arabi A, Shahraki T, Safi S. Von Hippel-Lindau disease and the eye, (in eng). J Ophthalmic Vis Res. Jan-Mar 2020;15(1):78\u201394. https:\/\/doi.org\/10.18502\/jovr.v15i1.5950.","DOI":"10.18502\/jovr.v15i1.5950"},{"key":"5694_CR13","doi-asserted-by":"publisher","unstructured":"Orlova KA, Crino PB. The tuberous sclerosis complex, (in eng), Ann N Y Acad Sci, vol. 1184, pp. 87\u2013105, Jan 2010, https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05117.x","DOI":"10.1111\/j.1749-6632.2009.05117.x"},{"key":"5694_CR14","doi-asserted-by":"publisher","unstructured":"Lam HC et al. p62\/SQSTM1 cooperates with hyperactive mTORC1 to regulate glutathione production, maintain mitochondrial integrity, and promote tumorigenesis, (in eng). Cancer Res, 77, 12, pp. 3255\u201367, Jun 15 2017, https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2458","DOI":"10.1158\/0008-5472.Can-16-2458"},{"key":"5694_CR15","doi-asserted-by":"publisher","unstructured":"Dias PB, et al. Optical coherence tomography detection of retinal neural loss in patients with tuberous sclerosis, (in eng). Int J Retina Vitreous. Feb 4 2024;10(1):15. https:\/\/doi.org\/10.1186\/s40942-024-00535-7.","DOI":"10.1186\/s40942-024-00535-7"},{"key":"5694_CR16","doi-asserted-by":"publisher","unstructured":"Singh L, et al. Epidemiology, diagnosis and genetics of retinoblastoma: ICMR consensus guidelines, (in eng). Indian J Pediatr. Nov 2024;91(11):1147\u201356. https:\/\/doi.org\/10.1007\/s12098-024-05085-2.","DOI":"10.1007\/s12098-024-05085-2"},{"key":"5694_CR17","doi-asserted-by":"publisher","unstructured":"Kaewkhaw R, Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment, (in eng), Cancers (Basel), vol. 12, no. 8, Aug 16 2020, https:\/\/doi.org\/10.3390\/cancers12082304","DOI":"10.3390\/cancers12082304"},{"key":"5694_CR18","doi-asserted-by":"publisher","unstructured":"Warda O, Naeem Z, Roelofs KA, Sagoo MS, Reddy MA. Retinoblastoma and vision, (in eng), Eye (Lond), vol. 37, no. 5, pp. 797\u2013808, Apr 2023, https:\/\/doi.org\/10.1038\/s41433-021-01845-y","DOI":"10.1038\/s41433-021-01845-y"},{"key":"5694_CR19","doi-asserted-by":"publisher","unstructured":"G\u00fcnd\u00fcz AK, Mirzayev I, Din\u00e7aslan H, \u00d6zalp Ate\u015f FS. Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: risk factors and treatment results (in eng). Eur J Ophthalmol. May 2022;32(3):1795\u2013803. https:\/\/doi.org\/10.1177\/11206721211023311.","DOI":"10.1177\/11206721211023311"},{"key":"5694_CR20","doi-asserted-by":"publisher","unstructured":"Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children initially treated with systemic carboplatin, (in eng), Ophthalmology, vol. 110, no. 10, pp. 1989-94; discussion 1994-5, Oct 2003, https:\/\/doi.org\/10.1016\/s0161-6420(03)00669-9","DOI":"10.1016\/s0161-6420(03)00669-9"},{"key":"5694_CR21","doi-asserted-by":"publisher","unstructured":"Li J et al. Nov., Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma, (in eng), Eye (Lond), vol. 36, no. 11, pp. 2106\u20132110, 2022, https:\/\/doi.org\/10.1038\/s41433-021-01693-w","DOI":"10.1038\/s41433-021-01693-w"},{"key":"5694_CR22","doi-asserted-by":"publisher","unstructured":"Kaliki S, Vempuluru VS, Priya Y, Mohamed A. Risk factors for recurrent retinoblastoma after intravenous chemotherapy, (in eng), Int Ophthalmol, vol. 41, no. 6, pp. 2033\u20132039, Jun 2021, https:\/\/doi.org\/10.1007\/s10792-021-01759-4","DOI":"10.1007\/s10792-021-01759-4"},{"key":"5694_CR23","doi-asserted-by":"publisher","unstructured":"Feng ZX, Zhao J, Zhang N, Jin M, Gallie B. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma, (in eng), Invest Ophthalmol Vis Sci, vol. 64, no. 11, p. 27, Aug 1 2023, https:\/\/doi.org\/10.1167\/iovs.64.11.27","DOI":"10.1167\/iovs.64.11.27"},{"key":"5694_CR24","doi-asserted-by":"publisher","unstructured":"Manukonda R, Narayana RV, Kaliki S, Mishra DK, Vemuganti GK. Emerging therapeutic targets for retinoblastoma, (in eng), Expert Opin Ther Targets, vol. 26, no. 11, pp. 937\u2013947, Nov 2022, https:\/\/doi.org\/10.1080\/14728222.2022.2158812","DOI":"10.1080\/14728222.2022.2158812"},{"key":"5694_CR25","doi-asserted-by":"publisher","unstructured":"Riccardi VM. Neurofibromatosis: past, present, and future, (in eng), N Engl J Med, vol. 324, no. 18, pp. 1283-5, May 2 1991, https:\/\/doi.org\/10.1056\/nejm199105023241812","DOI":"10.1056\/nejm199105023241812"},{"key":"5694_CR26","doi-asserted-by":"publisher","unstructured":"Ly KI, Blakeley JO. The Diagnosis and Management of Neurofibromatosis Type 1, (in eng), Med Clin North Am, vol. 103, no. 6, pp. 1035\u20131054, Nov 2019, https:\/\/doi.org\/10.1016\/j.mcna.2019.07.004","DOI":"10.1016\/j.mcna.2019.07.004"},{"key":"5694_CR27","doi-asserted-by":"publisher","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR. Health Supervision for Children With Neurofibromatosis Type 1, (in eng), Pediatrics, vol. 143, no. 5, May 2019, https:\/\/doi.org\/10.1542\/peds.2019-0660","DOI":"10.1542\/peds.2019-0660"},{"key":"5694_CR28","doi-asserted-by":"publisher","unstructured":"Abdolrahimzadeh B, Piraino DC, Albanese G, Cruciani F, Rahimi S. Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography, (in eng), clin ophthalmol. Pp 851\u2013 60. 2016;10. https:\/\/doi.org\/10.2147\/opth.S102830.","DOI":"10.2147\/opth.S102830"},{"issue":"2","key":"5694_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000507428","volume":"11","author":"S Abdolrahimzadeh","year":"2020","unstructured":"Abdolrahimzadeh S, Formisano M, Guglielmelli F, Amodeo S, Costa MC, Scuderi G. Unusual case of indolent choroidal alterations mimicking neurofibromatosis type 1, (in eng). Case Rep Ophthalmol. May-Aug. 2020;11(2):167\u201373. https:\/\/doi.org\/10.1159\/000507428.","journal-title":"May-Aug"},{"key":"5694_CR30","doi-asserted-by":"publisher","unstructured":"Moon KH et al. Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development, (in eng), Dev Cell, vol. 44, no. 1, pp. 13\u201328.e3, Jan 8., 2018, https:\/\/doi.org\/10.1016\/j.devcel.2017.11.011","DOI":"10.1016\/j.devcel.2017.11.011"},{"key":"5694_CR31","doi-asserted-by":"publisher","unstructured":"Plana-Pla A, Bielsa-Marsol I, Carrato-Mo\u00f1ino C. Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2, (in eng spa), Actas Dermosifiliogr, vol. 108, no. 7, pp. 630\u2013636, Sep 2017, https:\/\/doi.org\/10.1016\/j.ad.2016.12.007. Manifestaciones cut\u00e1neas de la neurofibromatosis tipo 2: inter\u00e9s diagn\u00f3stico y pron\u00f3stico.","DOI":"10.1016\/j.ad.2016.12.007"},{"key":"5694_CR32","doi-asserted-by":"publisher","unstructured":"Tamura R. Current Understanding of neurofibromatosis type 1, 2, and schwannomatosis, (in eng). Int J Mol Sci. May 29 2021;22(11). https:\/\/doi.org\/10.3390\/ijms22115850.","DOI":"10.3390\/ijms22115850"},{"key":"5694_CR33","doi-asserted-by":"publisher","unstructured":"Zhao D et al. Mar., iASPP is essential for HIF-1\u03b1 stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation, (in eng), Oncogene, vol. 41, no. 13, pp. 1944\u20131958, 2022, https:\/\/doi.org\/10.1038\/s41388-022-02234-9","DOI":"10.1038\/s41388-022-02234-9"},{"key":"5694_CR34","doi-asserted-by":"publisher","unstructured":"Berar OV, et al. Mammalian target of Rapamycin inhibitors for the treatment of astrocytic Hamartoma in tuberous sclerosis complex (TSC), (in eng). Graefes Arch Clin Exp Ophthalmol. Sep 2022;260(9):3061\u20138. https:\/\/doi.org\/10.1007\/s00417-022-05585-x.","DOI":"10.1007\/s00417-022-05585-x"},{"key":"5694_CR35","doi-asserted-by":"publisher","unstructured":"Licchetta L et al. Apr., Tuberous sclerosis complex in adulthood: focus on epilepsy prognosis, (in eng), Epilepsy Behav, vol. 153, p. 109688, 2024, https:\/\/doi.org\/10.1016\/j.yebeh.2024.109688","DOI":"10.1016\/j.yebeh.2024.109688"},{"key":"5694_CR36","doi-asserted-by":"publisher","unstructured":"Bacci GM, Polizzi S, Mari F, Conti V, Caputo R, Guerrini R. Atypical Ocular Coloboma in Tuberous Sclerosis-2: Report of Two Novel Cases, (in eng), J Neuroophthalmol, vol. 41, no. 3, pp. e363-e365, Sep 1 2021, https:\/\/doi.org\/10.1097\/wno.0000000000001099","DOI":"10.1097\/wno.0000000000001099"},{"key":"5694_CR37","doi-asserted-by":"publisher","unstructured":"Berry JL, Polski A, Cavenee WK, Dryja TP, Murphree AL, Gallie BL. The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene, (in eng), Genes (Basel), vol. 10, no. 11, Nov 1 2019, https:\/\/doi.org\/10.3390\/genes10110879","DOI":"10.3390\/genes10110879"},{"key":"5694_CR38","doi-asserted-by":"publisher","unstructured":"Le Rhun E et al. Nov., Molecular targeted therapy of glioblastoma, (in eng), Cancer Treat Rev, vol. 80, p. 101896, 2019, https:\/\/doi.org\/10.1016\/j.ctrv.2019.101896","DOI":"10.1016\/j.ctrv.2019.101896"},{"key":"5694_CR39","doi-asserted-by":"publisher","unstructured":"S.H. Baik et al. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer\u2019s Disease, (in eng), Cell Metab, vol. 30, no. 3, pp. 493\u2013507.e6, Sep 3., 2019, https:\/\/doi.org\/10.1016\/j.cmet.2019.06.005","DOI":"10.1016\/j.cmet.2019.06.005"},{"key":"5694_CR40","doi-asserted-by":"publisher","first-page":"1004978","DOI":"10.3389\/fonc.2022.1004978","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Li AM, Ye J. The magic bullet: niclosamide (in eng). Front Oncol. 2022;12:1004978. https:\/\/doi.org\/10.3389\/fonc.2022.1004978.","journal-title":"Front Oncol"},{"key":"5694_CR41","doi-asserted-by":"publisher","unstructured":"Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: Events of a metabolic disease, (in eng), Biochim Biophys Acta Rev Cancer, vol. 1876, no. 1, p. 188559, Aug 2021, https:\/\/doi.org\/10.1016\/j.bbcan.2021.188559","DOI":"10.1016\/j.bbcan.2021.188559"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05694-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:04:00Z","timestamp":1746875040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05694-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5694"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05694-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5838014\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the principles of the Declaration of Helsinki. Informed consent was obtained in writing from the parents or legal guardians of all participants before the procedure. The Ethics Committee of Hunan Children\u2019s Hospital granted ethical approval (No. HCHLL-2022-76).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors have given their approval for the final manuscript and consented to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}